- Home
- FAST vs ARGX Comparison
FAST vs ARGX Comparison
Compare FAST & ARGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAST
- ARGX
- Stock Information
- Founded
- FAST 1967
- ARGX 2008
- Country
- FAST United States
- ARGX Netherlands
- Employees
- FAST N/A
- ARGX N/A
- Industry
- FAST RETAIL: Building Materials
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FAST Consumer Discretionary
- ARGX Health Care
- Exchange
- FAST Nasdaq
- ARGX Nasdaq
- Market Cap
- FAST 47.1B
- ARGX 40.4B
- IPO Year
- FAST N/A
- ARGX 2017
- Fundamental
- Price
- FAST $78.41
- ARGX $556.87
- Analyst Decision
- FAST Hold
- ARGX Strong Buy
- Analyst Count
- FAST 9
- ARGX 20
- Target Price
- FAST $81.75
- ARGX $699.56
- AVG Volume (30 Days)
- FAST 3.9M
- ARGX 395.2K
- Earning Date
- FAST 04-11-2025
- ARGX 05-08-2025
- Dividend Yield
- FAST 2.00%
- ARGX N/A
- EPS Growth
- FAST N/A
- ARGX N/A
- EPS
- FAST 2.00
- ARGX 15.94
- Revenue
- FAST $7,610,300,000.00
- ARGX $2,643,062,000.00
- Revenue This Year
- FAST $9.74
- ARGX $60.97
- Revenue Next Year
- FAST $8.28
- ARGX $31.50
- P/E Ratio
- FAST $41.21
- ARGX $35.56
- Revenue Growth
- FAST 3.08
- ARGX 82.13
- 52 Week Low
- FAST $61.36
- ARGX $352.77
- 52 Week High
- FAST $84.88
- ARGX $678.21
- Technical
- Relative Strength Index (RSI)
- FAST 47.90
- ARGX 41.23
- Support Level
- FAST $78.09
- ARGX $529.11
- Resistance Level
- FAST $80.51
- ARGX $658.93
- Average True Range (ATR)
- FAST 1.77
- ARGX 15.71
- MACD
- FAST -0.41
- ARGX -4.50
- Stochastic Oscillator
- FAST 11.62
- ARGX 34.46
About FAST Fastenal Company
Fastenal opened its first fastener store in 1967 in Winona, Minnesota. Since then, it has greatly expanded its footprint as well as its products and services. Today, Fastenal serves its 400,000 active customers through approximately 1,600 branches, over 2,000 on-site locations, and 15 distribution centers. Since 1993, the company has added other product categories, but fasteners remain its largest category at about 30%-35% of sales. Fastenal also offers customers supply chain solutions, such as vending and vendor-managed inventory.
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.